State Street’s Icosavax, Inc. Common Stock ICVX Stock Holding History

State Street’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-617,999	Closed	-$9.74M	–	4451
2023 Q4	$9.74M	Buy	617,999 +83,966	+16%	+$809K	﹤0.01%	2610
2023 Q3	$4.14M	Buy	534,033 +30,836	+6%	+$256K	﹤0.01%	3015
2023 Q2	$5M	Buy	503,197 +42,194	+9%	+$338K	﹤0.01%	3000
2023 Q1	$2.67M	Buy	461,003 +1,718	+0.4%	+$14.8K	﹤0.01%	3238
2022 Q4	$3.65M	Buy	459,285 +9,298	+2%	+$39.9K	﹤0.01%	3175
2022 Q3	$1.42M	Buy	449,987 +82,635	+22%	+$517K	﹤0.01%	3505
2022 Q2	$2.1M	Buy	367,352 +8,308	+2%	+$64.8K	﹤0.01%	3457
2022 Q1	$2.53M	Buy	359,044 +141,175	+65%	+$2.22M	﹤0.01%	3477
2021 Q4	$4.99M	Buy	217,869 +32,286	+17%	+$834K	﹤0.01%	3242
2021 Q3	$5.49M	Buy	+185,583	New	+$6.29M	﹤0.01%	3188

State Street's ICVX Position: Q1 2024 in Review

State Street sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 617,999 shares — an estimated $9.74M sold.

State Street first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $9.74M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

State Street reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
State Street sold 617,999 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $9.74M.
State Street first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
State Street's Icosavax, Inc. Common Stock position peaked at $9.74M in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on State Street's 13F filing for Q1 2024, filed 15 May 2024.